COVID-19 Vaccination in Patients with Liver Disease
Date: Thursday, January 28, 2021 Moderators: Kyong-Mi Chang, MD, FAASLD | Gregory A. Poland, MDPresenters: Hugo R. Rosen, MD, FAASLD | Eleanor Barnes | Drew Weissman, M.D., Ph.D. | Onyema Ogbuagu, MBBCh, FACP, FIDSA
On January 28, 2021, AASLD hosted a webinar which discussed the development of the vaccine to battle COVID-19. Understanding the safety and efficacy of these vaccines in patients with liver disease is critical to our institutions, our patients and their families.
This webinar:
Discusses the clinical and immunological issues of conventional vaccines in patients with liver disease.
Reviews the safety of vaccines with adenoviral vectors in liver disease patients.
Reviews the safety of RNA vaccines in patients with liver disease.